(Q44650255)

5 December 2017

title

Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin (English)

1 reference

5 December 2017

Enhancement of proteolytic processing of the β-amyloid precursor protein by hyperforin (English)

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

31 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

31 March 2024

3

Walter E. Müller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609742

31 March 2024

author name string

Bettina Froestl

1

1 reference

5 December 2017

Barbara Steiner

2

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

full work available at URL

5 December 2017

https://api.elsevier.com/content/article/PII:S0006295203006294?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

https://api.elsevier.com/content/article/PII:S0006295203006294?httpAccept=text/plain

31 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

31 March 2024

published in

Biochemical Pharmacology

1 reference

5 December 2017

volume

66

1 reference

5 December 2017

issue

11

1 reference

5 December 2017

page(s)

2177-2184

1 reference

Secretases as targets for drug design in Alzheimer's disease

5 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease

31 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review

31 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Hypericum perforatum--a review of clinical studies

31 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

St. John's wort and depression: efficacy, safety and tolerability-an update

31 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Hyperforin--antidepressant activity by a novel mechanism of action

31 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

The involvement of sodium and calcium ions in the release of amino acid neurotransmitters from mouse cortical slices elicited by hyperforin

31 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Modulation of ion channels in rat neurons by the constituents of Hypericum perforatum.

31 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Studies on the antioxidative activity of phloroglucinol derivatives isolated from hypericum species

31 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

31 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase

31 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Effects of hyperforin on the fluidity of brain membranes

31 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells

31 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.

31 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines

31 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Stimulation of glutamate, aspartate and gamma-aminobutyric acid release from synaptosomes by hyperforin

31 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Hyperforin stimulates intracellular calcium mobilisation and enhances extracellular acidification in DDT1-MF2 smooth muscle cells

31 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Processing of the Amyloid Protein Precursor to Potentially Amyloidogenic Derivatives

31 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein

31 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

31 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

31 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, a selective inhibitor of vacuolar ATPases

31 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

The vacuolar H(+)-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type beta-amyloid precursor protein

31 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Exchanging the extracellular domain of amyloid precursor protein for horseradish peroxidase does not interfere with alpha-secretase cleavage of the beta-amyloid region, but randomizes secretion in Madin-Darby canine kidney cells

31 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Effect of alkalizing agents on the processing of the beta-amyloid precursor protein.

31 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Novel effects of FCCP [carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone] on amyloid precursor protein processing

31 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

The molecular mechanism of action of the proton ionophore FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone).

31 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Plasma membrane depolarization and disturbed Na+ homeostasis induced by the protonophore carbonyl cyanide-p-trifluoromethoxyphenyl-hydrazon in isolated nerve terminals

31 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Effects of mitochondrial uncouplers on intracellular calcium, pH and membrane potential in rat carotid body type I cells.

31 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation

31 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Phosphorylation of the beta-amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2

31 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Quick and accurate method to convert BCECF fluorescence to pHi: Calibration in three different types of cell preparations

31 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies

31 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation

31 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein

31 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

31 March 2024

Golgi-disturbing agents

46

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Hyperforin inhibits vesicular uptake of monoamines by dissipating pH gradient across synaptic vesicle membrane

31 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

31 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content

31 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

31 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

31 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Enhanced processing of APP induced by IL-1 beta can be reduced by indomethacin and nordihydroguaiaretic acid

31 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors.

31 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.BCP.2003.08.010

31 March 2024

Identifiers

1 reference

5 December 2017

1 reference